Valproate and neuroprotection.
Vajda
F J E
FJ
Australian Centre for Clinical Neuropharmacology - Raoul Wallenberg Centre, St Vincent's Hospital and University of Melbourne, Fitzroy, VIC 3065, Australia. vadja@svhm.org.au
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology / Q000627:therapeutic use*; D015415:Biomarkers; D004827:Epilepsy / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D018377:Neurotransmitter Agents / Q000502:physiology; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects; D014635:Valproic Acid / Q000494:pharmacology / Q000627:therapeutic use*
D000927:Anticonvulsants; D015415:Biomarkers; D018696:Neuroprotective Agents; D018377:Neurotransmitter Agents; D016194:Receptors, N-Methyl-D-Aspartate; D014635:Valproic Acid